GlassScriptPhysician profile
Brian Matthew Curtin
NPI 1225179526
$437,045.14
in general payments reported to CMS, 2019-2025
27 companies · $171K in 2025
The $171K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $30K · 2021: $27K · 2022: $42K · 2023: $27K · 2024: $83K · 2025: $171K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $177K · Consulting Fee: $91K · Travel and Lodging: $8,276 · Food and Beverage: $3,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $176,977.45 |
| Consulting Fee | $91,452.09 |
| Travel and Lodging | $8,276.38 |
| Food and Beverage | $3,755.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $250,734.51 | 2021-2025 | Velys, Pinnacle, Actis |
| Medical Device Business Services, INC. | $80,870.59 | 2019-2024 | Velys, Corail, Pinnacle |
| Zimmer Biomet Holdings, INC. | $39,933.33 | 2019-2025 | Rosa |
| Encore Medical, LP | $39,828.96 | 2022-2025 | Djo Surgical |
| Vertex Pharmaceuticals Incorporated | $16,586.27 | 2025 | |
| Heron Therapeutics, INC. | $3,300.42 | 2019-2025 | Zynrelef |
| Stryker Corporation | $1,805.06 | 2019-2025 | Mako, T7 |
| Ethicon INC. | $1,040.00 | 2022 | |
| Depuy Synthes Sales INC. | $336.39 | 2022-2025 | Milagro |
| Smith+Nephew, INC. | $324.96 | 2022-2025 | Real Intelligence, Legion Revision, Renasys Touch |
| Medacta USA, INC. | $272.36 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $236.11 | 2024-2025 | Iovera, Exparel, Zilretta |
| Medtronic, INC. | $182.37 | 2022-2024 | Plasmablade(Tm) |
| Lima USA, INC. | $171.37 | 2019 | |
| Intellijoint Surgical INC. | $168.35 | 2024 | Intellijoint Hip |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $162.42 | 2019 | |
| Davol INC. | $160.13 | 2023 | Arista Ah Flexitip |
| Heraeus Medical, LLC. | $133.35 | 2019-2023 | Palacos |
| Next Science LLC | $132.07 | 2021 | |
| Peerless Surgical INC. | $124.70 | 2020 | |
| Think Surgical, INC. | $122.84 | 2025 | |
| Medtronic USA, INC. | $108.50 | 2019 | |
| Onkos Surgical, INC. | $104.57 | 2023 | Eleos Limb Salvage System |
| Osteoremedies, LLC | $100.69 | 2024 | Biowash Surgical Irrigation, Osteoboost Select 10cc, Biobrush |
| Bioventus LLC | $52.69 | 2022 | |
| Ethicon US, LLC | $36.67 | 2025 | Vistaseal |
| Radius Health, INC. | $15.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Curtin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.